AmpliPhi Biosciences Closes $7 Million Private Placement

Published: Jun 27, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RICHMOND, Va. & COLWORTH, England & SYDNEY--(BUSINESS WIRE)--AmpliPhi BioSciences Corp. (OTC:APHB), the world leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today the completion of a successful private placement of convertible preferred stock with gross proceeds of $7 million. The financing was led by established life-sciences investors RA Capital Management and Third Security, LLC, with participation from BioScience Managers Pty Ltd.

Help employers find you! Check out all the jobs and post your resume.

Back to news